Psychologists in Harker Heights, TX Accepting Medicare
8 Psychologists found. Showing 1 - 8
 Dr. Ginger Marie Kinsey, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 880 Prospector Trl Ste 100, Harker Heights, TX 76548 Phone: 254-690-1512 Fax: 254-690-1532 |
 Michael E. Campbell, PH.D. Psychologist - Health Service Medicare: Not Enrolled in Medicare Practice Location: 880 Prospector Trail, Suite 100, Harker Heights, TX 76548 Phone: 254-690-1512 Fax: 254-690-1532 |
Christine June Svoboda, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 120 W Centex Expy, Suite 202, Harker Heights, TX 76548 Phone: 254-680-7553 Fax: 888-505-9607 |
Valeta M Cooper, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 625 E Veterans Memorial Blvd, Harker Heights, TX 76548 Phone: 417-612-0250 |
Shari L Hogue, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 100 W Central Texas Expy, Suite 212, Harker Heights, TX 76548 Phone: 254-383-6063 Fax: 254-953-3236 |
Dr. Christina Nicole Radmer, PSYD, LP Psychologist Medicare: Accepting Medicare Assignments Practice Location: 880 Prospector Trl Ste 100, Harker Heights, TX 76548 Phone: 254-690-1512 |
Susan Gail Matlock-hetzel, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 326 Morgan St, Harker Heights, TX 76548 Phone: 254-724-2585 |
Dr. Amy Lynn Dillree, PHD BCBA Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 4019 Lakecliff Dr, Harker Heights, TX 76548 Phone: 254-833-3744 Fax: 254-393-1253 |
News Archive
Statewide H1N1 Vaccine Provider Registration System from Upp Technology
Supporting directives from the U.S. Centers for Disease Control and Prevention, Upp Software, a business unit of Upp Technology, Inc., has developed, delivered and now offers a Statewide H1N1 Vaccine Provider Registration System to accommodate thousands of vaccine providers' ordering and reporting needs.
Injuries could increase for players returning to contact sports after prolonged training restrictions
As professional sports look to make a phased return behind closed doors across much of Europe, researchers from the University of Bath caution that the prolonged individual training players have been exposed to for months is insufficient to help athletes maintain the physical fitness and mental strength they need for competition.
FDA grants Orphan Drug Designation to Alnylam ALN-AT3 for treatment of hemophilia B
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the U.S. Food & Drug Administration (FDA) has granted an Orphan Drug Designation to ALN-AT3 as a therapeutic for the treatment of hemophilia B.
Phase 3 trial results of Horizon Therapeutics's HZT-501 presented at the ACG meeting
Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today presented an analysis from two pivotal Phase 3 trials (REDUCE-1 and REDUCE-2) evaluating its lead investigational compound HZT-501, a combination of ibuprofen with high-dose famotidine.
Insurance and HMO interests fighting health care reform with huge money
A campaign finance watchdog's analysis of insurance and HMO political contributions and lobbying expenses found the industries spent $126,430,438 over the first half of 2009 and $585,725,712 over the past two and a half years to influence public policy and elected officials.
› Verified 6 days ago
Counselors
Pharmacists
Dentists
Occupational Therapists
Clinical Social Workers
Psychologists